| Literature DB >> 25794169 |
Ioannis Pantziaras1, Uno Fors2, Solvig Ekblad1.
Abstract
BACKGROUND: Virtual patients are now widely accepted as efficient and safe training tools in medical education, but very little is known about their implementation in psychiatry, especially in transcultural clinical care of traumatized refugee patients.Entities:
Mesh:
Year: 2015 PMID: 25794169 PMCID: PMC4368761 DOI: 10.1371/journal.pone.0119754
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Screenshot of the Virtual Patient system illustrating the history-taking interview.
The user can interact with the patient by choosing relevant questions divided in searchable appropriate categories and sub-categories. For illustrative purposes only, used with written permission by the portrayed model.
The four generated clusters of confidence with examples of items, number of included items (n) and Cronbach’s α.
| Cluster | Examples of included items | Items (N) | Cronbach-α |
|---|---|---|---|
| Identify and evaluate trauma-related diagnoses and disability | Identify post-traumatic stress disorder (PTSD); Ask about the patient’s/client’s "trauma story"; Use screening instruments | 12 | 0.90 |
| Treat and manage trauma-related diagnoses and disability | Treat trauma-related disability; Reinforce and teach positive coping behaviors for patients; Effectively use psycho-therapeutic medications | 16 | 0.92 |
| Treat victims of torture | Treat the mental health problems of torture survivors; Care for the spiritual problems of torture survivors; Care for the legal problems of torture survivors | 6 | 0.88 |
| Elements of intercultural communication | Adapt your work to different cultures and societies; Work effectively with an interpreter; Be culturally attuned to differences in meaning and interpretation of emotional upset between cultures | 5 | 0.87 |
Changes in mean confidence scores between pre- and post-test, by cluster and gender.
| N | Data | Mean | SD | Δ | SD | CI | d | t | p |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| All (N = 32) | Pre-test | 3.86 | 0.73 | ||||||
| Post-test | 4.20 | 0.80 | -0.34 | 0.38 | -0.48, -0.21 | 0.89 | -5.09 | <0.0001 | |
| Male (N = 12) | Pre-test | 4.13 | 0.21 | ||||||
| Post-test | 4.48 | 0.23 | -0.35 | 0.46 | -0.65, -0.06 | 0.76 | -2.68 | 0.02 | |
| Female (N = 20) | Pre-test | 3.70 | 0.70 | ||||||
| Post-test | 4.03 | 0.79 | -0.34 | 0.34 | -0.50, -0.18 | 1 | -4.42 | 0.0003 | |
|
| |||||||||
| All (N = 32) | Pre-test | 3.98 | 0.75 | ||||||
| Post-test | 4.46 | 0.83 | -0.47 | 0.47 | -0.64, -0.31 | 1 | -5.73 | <0.0001 | |
| Male (N = 12) | Pre-test | 4.23 | 0.75 | ||||||
| Post-test | 4.65 | 0.88 | -0.42 | 0.44 | -0.69, -0.14 | 0.95 | -3.31 | 0.007 | |
| Female (N = 20) | Pre-test | 3.83 | 0.72 | ||||||
| Post-test | 4.34 | 0.80 | -0.51 | 0.49 | -0.74, -0.28 | 1 | -4.61 | 0.0002 | |
|
| |||||||||
| All (N = 32) | Pre-test | 3.92 | 0.81 | ||||||
| Post-test | 4.19 | 0.81 | -0.27 | 0.33 | -0.39, -0.15 | 0.82 | -4.50 | 0.0001 | |
| Male (N = 12) | Pre-test | 4.14 | 0.85 | ||||||
| Post-test | 4.45 | 0.80 | -0.31 | 0.36 | -0.54, -0.08 | 0.86 | -2.99 | 0.01 | |
| Female (N = 20) | Pre-test | 3.79 | 0.78 | ||||||
| Post-test | 4.03 | 0.79 | -0.24 | 0.32 | -0.39, -0.09 | 0.75 | -3.30 | 0.004 | |
|
| |||||||||
| All (N = 32) | Pre-test | 3.29 | 0.92 | ||||||
| Post-test | 3.76 | 0.91 | -0.46 | 0.69 | -0.71, -0.22 | 0.67 | -3.80 | 0.0006 | |
| Male (N = 12) | Pre-test | 3.57 | 0.97 | ||||||
| Post-test | 4 | 0.86 | -0.43 | 0.79 | -0.93, 0.07 | 0.54 | -1.88 | NS | |
| Female (N = 20) | Pre-test | 3.13 | 0.87 | ||||||
| Post-test | 3.61 | 0.93 | -0.48 | 0.63 | -0.78, -0.18 | 0.76 | -3.38 | 0.003 | |
|
| |||||||||
| All (N = 32) | Pre-test | 3.70 | 0.91 | ||||||
| Post-test | 4.02 | 0.98 | -0.32 | 0.72 | -0.58, -0.06 | 0.44 | -2.50 | 0.02 | |
| Male (N = 12) | Pre-test | 3.92 | 0.83 | ||||||
| Post-test | 4.35 | 0.86 | -0.43 | 1.03 | -1.09, 0.22 | 0.42 | -1.46 | NS | |
| Female (N = 20) | Pre-test | 3.57 | 0.95 | ||||||
| Post-test | 3.82 | 1.02 | -0.25 | 0.47 | -0.47, -0.03 | 0.53 | -2.37 | 0.03 | |